The Nevada Pharmacy Board has fined three individuals and a Texas-based private membership association for their roles in providing peptide injections at a Las Vegas anti-aging conference where two women became critically ill last year.
The board issued $10,000 fines each to Dr. Kent Holtorf, a California-based anti-aging physician, and Han Bao Nguyen, a pharmacist who works at Holtorf's practice. Both are licensed in California but do not have authorization to practice in Nevada. The board also fined Michael McNeal, described as an 'integrative health coach,' $5,000. Additionally, Forgotten Formula, the Texas-based group accused of mailing the peptides to Nevada, received a $10,000 fine.
The incident occurred in July at the Revolution Against Aging and Death Festival, known as RAADFest, an event organized by an Arizona-based organization promoting pathways to an 'unlimited lifespan.' At Holtorf's booth, two women received peptide injections and subsequently required emergency transport to hospitals where they were intubated. Both have since recovered.
What the Left Is Saying
Consumer protection advocates and health policy experts are emphasizing the need for stronger oversight of the peptide industry. The Nevada Pharmacy Board's actions represent an important step toward holding practitioners accountable, according to supporters of regulation.
Health and Human Services Secretary Robert F. Kennedy Jr., who has been a proponent of peptide therapies, recently stated that the FDA plans to reclassify 14 peptides currently listed as unsafe. Critics argue this could further endanger patients and undermine existing safety standards.
The FDA has approved peptide-based medications for treating serious conditions such as diabetes and cancer, but the agency has identified 19 popular peptides used in anti-aging treatments as posing 'significant safety risks.' Compounding pharmacies are prohibited from dispensing these substances. Progressive health advocates argue this regulatory framework exists precisely to protect patients from unregulated treatments.
What the Right Is Saying
Forgotten Formula, the Texas-based private membership association fined $10,000, is challenging the board's jurisdiction. The group contends it has a constitutional right to conduct private transactions with its members and argues these transactions occur 'outside the scope' of state commercial regulations.
Michael Blake Fiveash, co-founder and first trustee of Forgotten Formula, told ProPublica that pharmacy board regulations do not apply to his association because it offers services only to members who have signed agreements. This argument echoes broader libertarian critiques of state regulatory authority over private transactions between consenting adults.
Some conservative commentators have raised questions about whether the board's enforcement targets legitimate medical innovation versus actual harm. They note that while the two women were hospitalized, they have since recovered, and argue that regulatory overreach could stifle advances in longevity science.
What the Numbers Show
The Nevada Pharmacy Board issued $35,000 in total fines across four respondents: Dr. Kent Holtorf ($10,000), Han Bao Nguyen ($10,000), Michael McNeal ($5,000) and Forgotten Formula ($10,000). Both Holtorf and Nguyen were fined for practicing in Nevada without state licensure.
The two women hospitalized after receiving peptide injections represent the most serious documented adverse events from the festival. The board was unable to determine why the women became ill, including whether the injections were contaminated or represented an adverse reaction. Investigators could not obtain the products for testing.
The FDA has identified 19 peptides commonly used in anti-aging treatments as posing 'significant safety risks.' The injections administered to both women included at least one peptide on this list, according to the pharmacy board's citations. The agency permits compounding pharmacies to dispense some peptides but prohibits dispensing those on the safety list.
The FDA's planned reclassification of 14 peptides currently listed as unsafe could significantly alter the regulatory landscape for peptide therapies. If reclassified, compounding pharmacies would be permitted to dispense these substances.
The Bottom Line
The Nevada Pharmacy Board's enforcement action represents one of the most significant regulatory responses to date regarding peptide therapies used for anti-aging purposes. The case highlights the tension between growing consumer demand for longevity treatments and an evolving regulatory framework that struggles to keep pace with a booming gray market.
The board has notified California licensing authorities about the fines, which could result in additional discipline against Holtorf and Nguyen. The FDA has also been notified of the incident. Observers will watch whether other states pursue similar enforcement actions, particularly as the FDA considers reclassifying certain peptides that currently face restrictions.
For patients considering peptide therapies, health experts recommend verifying practitioner licensing status, understanding which substances are FDA-approved versus compounded, and consulting with licensed medical professionals about potential risks. The incident at RAADFest underscores the importance of due diligence when seeking anti-aging treatments that exist in a regulatory gray zone.